FOXP3 and neoplasm: Although neither GO-Y022 treatment (Figures 3B, C, F, G) nor 2DG (50) demonstrated a minor effect on the stability of Foxp3+ Tregs in vitro, combined treatment with GO-Y022 and 2DG could affect the Foxp3+ Treg generation and stability in the tumor microenvironment.